These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 25384507)

  • 1. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
    Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
    Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes.
    Zhang YK; Zhu WY; He JY; Chen DD; Huang YY; Le HB; Liu XG
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1641-50. PubMed ID: 22618509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
    Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
    Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
    Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
    Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
    Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
    J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abberent expression of oncogenic and tumor-suppressive microRNAs and their target genes in human adenocarcinoma alveolar basal epithelial cells.
    Tafsiri E; Darbouy M; Shadmehr MB; Cho WC; Karimipoor M
    J Cancer Res Ther; 2016; 12(1):395-400. PubMed ID: 27072269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
    Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
    Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
    Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
    Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.
    Bandi N; Vassella E
    Mol Cancer; 2011 May; 10():55. PubMed ID: 21575235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.